ArticleCancers2022

Targeting the Non-Canonical NF-κB Pathway in Chronic Lymphocytic Leukemia and Multiple Myeloma.

Thomas A Burley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.